Trial Profile
Influence of insulin therapy in non-diabetic patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease (COPD).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 06 Oct 2011 New trial record